Status:
COMPLETED
Rehabiliation Using HUBER 360 to Reduce the Risk of Falls
Lead Sponsor:
University of Liege
Conditions:
Rehabilitation
Exercise Therapy
Eligibility:
All Genders
Phase:
NA
Brief Summary
Aim: The aim of the present study was to analyse the effects of training performed on a rotating, motorised platform (the Huber/SpineForce device from LPG Systems, Valence, France) intended to reduce ...
Eligibility Criteria
Inclusion
- Patient benefiting from a physiotherapy rehabilitation program at the CHU Liège, CNRF
- Patient presenting a pathological situation justifying functional rehabilitation with HUBER 360®
- Patient presenting any pathology not constituting an exclusion criterion
- Patient giving informed consent to research.
Exclusion
- Cardiac or respiratory or neurological or rheumatological disease incompatible with physical activity ;
- Joint inflammation;
- Rheumatic disease in acute phase;
- Recent trauma, infection of the musculoskeletal system;
- Fever;
- Venous thrombosis ;
- Discopathy in acute phase;
- Neuropsychological problems that do not allow to integrate the instructions or other serious psychological problems;
- Cardiovascular diseases and any progressive, chronic, counter-indicative disease;
- Large anatomical deformities.
Key Trial Info
Start Date :
December 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 2 2022
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04687293
Start Date
December 9 2020
End Date
November 2 2022
Last Update
May 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Liège, CNRF
Tinlot, Liège, Belgium, 4557